Status:
ACTIVE_NOT_RECRUITING
REFLECTION: A Clinical Practice Learning Program for Galleri®
Lead Sponsor:
GRAIL, Inc.
Conditions:
Early Detection of Cancer
Cancer
Eligibility:
All Genders
22+ years
Brief Summary
REFLECTION is a multi-center, prospective, non-interventional, cohort study that will enroll approximately 14,000 individuals who have opted to be screened with Galleri®, a blood-based, multi-cancer e...
Eligibility Criteria
Inclusion
- Participants are eligible to be included in the study only if all of the following criteria apply:
- Participant has the ability to understand and the willingness to sign a written informed consent form (ICF);
- Participant is at least 22 years old at the time of consent;
- A provider or their designee has ordered the Galleri® test; and
- Participant has the ability to comprehend the participant questionnaires.
Exclusion
- There are no exclusions
Key Trial Info
Start Date :
August 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2026
Estimated Enrollment :
14633 Patients enrolled
Trial Details
Trial ID
NCT05205967
Start Date
August 23 2021
End Date
October 30 2026
Last Update
November 26 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Vincere Cancer Center
Scottsdale, Arizona, United States, 85260
2
Providence
Burbank, California, United States, 91505
3
Providence, St. Jude
Fullerton, California, United States, 92835
4
Providence, Mission
Mission Viejo, California, United States, 92691